[Heart transplantation in infants--a new option]
Related Experiment Videos
Insights
Orthotopic heart transplantation offers a superior quality of life for infants with end-stage heart failure. This pediatric heart transplant approach shows promising survival rates and no signs of rejection in early follow-up.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Transplantation Medicine
Background:
- Orthotopic heart transplantation is a recognized treatment for end-stage congestive heart failure in adults.
- Limited experience and significant objections exist regarding its application in infants.
- Pediatric heart transplantation in Germany was scarce before this study.
Observation:
- Ten pediatric patients underwent orthotopic heart transplantation between March 1988 and the study period.
- Patient cohort included infants with congestive cardiomyopathy, endocardial fibroelastosis, and complex congenital heart defects like hypoplastic left heart syndrome.
- The study involved patients ranging from newborns to 16 years of age.
Findings:
- Six out of ten pediatric patients survived the procedure and are in good clinical condition at home.
- No evidence of chronic rejection or graft atherosclerosis was observed in the surviving infants during the follow-up period.
- The first successful orthotopic heart transplant in a German newborn demonstrated superior clinical outcomes compared to palliative interventions.
Implications:
- Orthotopic heart transplantation is a viable and effective therapeutic option for infants with complex cardiac malformations and end-stage heart failure.
- This approach significantly improves the clinical course and quality of life for pediatric recipients.
- Further research and broader adoption of pediatric heart transplantation are warranted given the positive outcomes.
Abstract:
Nowadays orthotopic heart transplantation is world wide accepted as a therapeutic concept in endstage congestive heart failure. Concerning infants, there are still major objections against this kind of therapy and especially in our country exists only very limited experience. Since march 1988 we have performed an orthotopic heart transplantation in 10 pediatric patients: 5 infants (2-16 years of age) with congestive cardiomyopathy, 1 newborn with endocardial fibroelastosis, 3 newborns with hypoplastic left heart syndrome, and finally 1 infant at the age of 2 years with AV-canal and hypoplastic left ventricle. Until now 6 infants survived and are all at home and in good clinical condition. There have been no signs for chronic rejection or graft atherosclerosis up till now. As demonstrated in the example of the newborn, in whom we performed the first successfully orthotopic heart transplantation in Germany, the clinical course and quality of life are superior to those after other palliative procedures in complex cardiac malformations.